References and Notes
1a
Alcaide B.
Saez E.
Eur. J. Org. Chem.
2005,
1680
1b
Kuethe JT.
Wong A.
Qu CX.
Smitrpvich J.
Davies IW.
Hughes DL.
J. Org. Chem.
2005,
70:
2555
1c
Yamamoto H.
Futatsugi K.
Angew. Chem. Int. Ed.
2005,
44:
1924
1d
Kaufman TS.
Synthesis
2005,
339
2a
Mori M.
Chem. Pharm. Bull.
2005,
53:
457
2b
Alfonsi M.
Arcadi A.
Aschi M.
Bianchi G.
Marinelli F.
J. Org. Chem.
2005,
70:
2265
2c
Hultzsch KC.
Adv. Synth. Catal.
2005,
347:
367
2d
Zhu GG.
Tong XF.
Cheng J.
Sun YH.
Li D.
Zhang ZG.
J. Org. Chem.
2005,
70:
1712
2e
Negishi E.
Dalton Trans.
2005,
629
3a
Schreiner PR.
Navarro-Vazquez A.
Prall M.
Acc. Chem. Res.
2005,
38:
29
3b
Echvarren AM.
Nevado C.
Chem. Soc. Rev.
2004,
33:
431
3c
Aubert C.
Buisine O.
Malacria M.
Chem. Rev.
2002,
102:
813
3d
Trost BM.
Hashmi ASK.
Ball RG.
Adv. Synth. Catal.
2001,
343:
490
3e
Trost BM.
Krische MJ.
Synlett
1998,
1
For recent reviews, see:
4a
Park KH.
Chung YK.
Synlett
2005,
545
4b
Gibson SE.
Lewis SE.
Mainolfi N.
J. Organomet. Chem.
2004,
689:
3873
4c
Morimoto T.
Kakiuchi K.
Angew. Chem. Int. Ed.
2004,
43:
5580
4d
Bonaga LVR.
Krafft ME.
Tetrahedron
2004,
60:
9795
4e
Gibson SE.
Stevenazzi A.
Angew. Chem. Int. Ed.
2003,
42:
1800
5a
Wender PA.
Deschamps NM.
Gamber GG.
Angew. Chem. Int. Ed.
2003,
42:
1853
5b
Wender PA.
Croatt MP.
Deschamps NM.
J. Am. Chem. Soc.
2004,
126:
5948
For recent reviews, see:
6a
Kappe CO.
Angew. Chem. Int. Ed.
2004,
43:
6250
6b
Hayes BL.
Aldrichimica Acta
2004,
37:
66
6c
Blackwell HE.
Org. Biomol. Chem.
2003,
1:
1251
6d
Kuhnert N.
Angew. Chem. Int. Ed.
2002,
41:
1863
6e
Lidström P.
Tierney J.
Wathey B.
Westman J.
Tetrahedron
2001,
57:
9225
6f
Gabriel C.
Gabriel S.
Grant EH.
Halstead BSJ.
Mingos DMP.
Chem. Soc. Rev.
1998,
27:
213
7a
Hilt G.
Smolko KI.
Angew. Chem. Int. Ed.
2003,
42:
2795
7b
Ma B.
Snyder JK.
Organometallics
2002,
21:
4688
7c
Chen Y.
Kiattansakul R.
Ma B.
Snyder JK.
J. Org. Chem.
2001,
66:
6932
8a
Brummond KM.
Kerekes AD.
Wan H.
J. Org. Chem.
2002,
67:
5156
8b
Brummond KM.
Chen H.
Fischer KD.
Kerekes AD.
Rickards B.
Sill PC.
Geib SJ.
Org. Lett.
2002,
4:
1931
8c
Brummond KM.
Wan H.
Kent JL.
J. Org. Chem.
1998,
63:
6535
9 Crystal data for 2a: monoclinic, P21/a, a = 11.7068 (14), b = 15.7393 (17), c = 13.9213 (12) Å, β = 90.707 (6)°, limiting indices -11 £ h £ 14, -15 £ k £ 18, -15 £ l £ 17, reflections collected/unique 12136/4429 (R
int = 0.2320), final R indices [I > 2σ(I)] R1 = 0.0831, wR2 = 0.1130. For 5h: triclinic, P-1, a = 6.5446 (3), b = 11.3786 (9), c = 13.9632 (13)Å, α = 105.233 (3), β = 99.165 (5), γ = 101.332 (4)°, limiting indices -5 £ h £ 8, -14 £ k £ 11, -15 £ l £ 18, reflections collected/unique 5277/4305 (R
int = 0.0246), final R indices [I > 2σ(I)] R1 = 0.0577, wR2 = 0.1240. Crystallographic data for 2a and 5h have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication numbers of CCDC 287305 and 287306, respectively. These data can be obtained free charge via www.ddcd.cam.ac.uk/consts/retrieving.html [or from the Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB21EZ, UK; fax: +44 (1223)336033; or deposit@ddcd.cam.ac.uk].
10
General Comments.
Thin-layer chromatography (TLC) was performed on 0.25 mm Merck silica gel coated plates treated with a UV (254 nm) and acidic p-anisaldehyde stain followed by gentle heating. TLC plates were visualized by ultraviolet light and treatment with acidic p-anisaldehyde staining solution. THF was purified by distillation from sodium/benzophenone under nitrogen, toluene was distilled from sodium under nitrogen, CH2Cl2 was distilled form P2O5 under nitrogen. Reagents were purchased from Aldrich Chemical Co. and Strem Chemical Co. and were used as received. All yields are based upon isolated material. 1H NMR and 13C NMR spectra were obtained with a Bruker 300 MHz spectrometer. Coupling constants (J values) are reported in Hertz (Hz), and spin multiplicities are indicated by the following symbols: s(singlet), d(doublet), t(triplet), q(quartet), m(multiplet). Infrared spectra were recorded on a Shimadzu IR-470 spectrometer. IR spectra were obtained as films on NaCl by evaporation of solvent or in CHCl3 solution. Elemental analyses were done at the National Center for Inter-University Research Facilities, Seoul National University. High resolution mass spectra were obtained at Korea Basic Science Institute (Daegu, Korea). High resolution mass spectrometry (HRMS) data are reported in the form of m/z (intensity relative to base peak = 100). Microwave reactions were carried out on a CEM Discover microwave reactor with a circular, single mode, self-tuning microwave applicator operating at 2450 MHz. The reaction vessel was purged with nitrogen prior to the addition of reagents. Flash chromatography was performed using Merck Silica Gel 60 (230-400 mesh). Diffraction data of 2a and 5h for structure determination were measured by an Enraf-Nonius CCD single-crystal X-ray diffractometer at r.t. using graphite-monochromated MoKα radiation (λ = 0.71013 Å). Preliminary orientation matrixes and unit cell parameters were obtained from the peaks of the first 10 frames and then refined using the whole data set. Frames were integrated and corrected for Lorentz and polarization effects using DENZO. The structure was solved by direct methods using SHELXS-97 and refined by full-matrix least squares fitting with SHELXL-97. All non-hydrogen atoms were refined anisotropically, and all hydrogen atoms not involving hydrogen bonding were treated as idealized contributions.
Analytical Data.
6-Phenyl-4-propenyl-3a,4-dihydro-1
H
,3
H
-cyclo-penta[
c
]furan-5-one (2a).
1H NMR (CDCl3): δ = 1.77 (d, J = 4.9 Hz, 3 H), 2.96 (m, 1 H), 3.24 (m, 1 H), 3.32 (dd, J = 7.6, 11.0 Hz, 1 H), 4.43 (t, J = 7.4 Hz, 1 H), 4.61 (d, J = 16.5 Hz, 1 H), 4.93 (dd, J = 1.5, 16.5 Hz, 1 H), 5.67 (m, 2 H), 7.36 (m, 3 H), 7.53 (m, 2 H) ppm. 13C NMR (CDCl3): δ = 18.3, 50.4, 56.5, 66.7, 71.4, 126.4, 128.2, 128.8, 128.9, 130.0,130.9, 133.5, 174.6, 206.6 ppm. IR: νCO = 1706 cm-1. HRMS: m/z calcd for C16H16O2: 240.1150; found: 240.1151. Anal. Calcd for C16H16O2: C, 79.96; H, 6.72. Found: C, 80.17; H, 6.88.
6-Butyl-4-propenyl-3a,4-dihydro-1
H
,3
H
-cyclo-penta[
c
]furan-5-one (2b).
1H NMR (CDCl3): δ = 0.90 (t, J = 7.2 Hz, 3 H), 1.31 (m, 2 H), 1.43 (m, 2 H), 1.75 (d, J = 5.8 Hz, 3 H), 2.14 (qui, J = 7.4 Hz, 1 H), 2.27 (qui, J = 7.4 Hz, 1 H) 2.74 (m, 1 H), 3.08 (m, 1 H), 3.27 (dd, J = 8.0, 11.1 Hz, 1 H), 4.36 (t, J = 7.8 Hz, 1 H), 4.51 (dd, J = 0.7, 15.7 Hz, 1 H), 4.61 (dd, J = 1.1, 15.7 Hz, 1 H), 5.60 (m, 2 H) ppm. 13C NMR (CDCl3): δ = 14.0, 18.4, 22.8, 24.5, 30.0, 50.4, 55.1, 65.3, 71.8, 126.6, 129.7, 135.7, 173.5, 208.9 ppm. IR: νCO = 1707 cm-1. HRMS: m/z calcd for C14H20O2: 220.1463; found: 220.1467.
6-Phenyl-4-propenyl-2-(toluene-4-sulfonyl)-2,3,3a,4-tetrahydro-1
H
-cyclopenta[
c
]pyrrol-5-one (2c).
1H NMR (CDCl3): δ = 1.75 (d, J = 6.0 Hz, 3 H), 2.40 (s, 3 H), 2.66 (dd, J = 9.3, 10.8 Hz, 1 H), 2.86 (m, 1 H), 3.14 (m, 1 H), 4.06 (m, 1 H), 4.13 (d, J = 8.7 Hz, 1 H), 4.65 (dd, J = 1.7, 17.1 Hz, 1 H), 5.60 (m, 2 H), 7.31 (d, J = 8.1 Hz, 2 H), 7.35-7.47 (m, 5 H), 7.72 (d, J = 8.3 Hz, 2 H) ppm. 13C NMR (CDCl3): δ = 14.3, 18.4, 21.7, 22.8, 31.8, 48.6, 48.8, 51.9, 56.9, 125.8, 127.6, 128.3, 128.9, 129.1, 130.1, 130.2, 130.4, 133.6, 134.9, 144.3, 169.3, 205.4 ppm. IR: νCO = 1709 cm-1. HRMS: m/z calcd for C23H23O3NS: 393.1399; found: 393.1400.
4-Propenyl-2-(toluene-4-sulfonyl)-2,3,3a,4-tetrahydro-1
H
-cyclopenta[
c
]pyrrol-5-one (2d).
1H NMR (CDCl3): δ = 1.73 (d, J = 7.2 Hz, 3 H), 2.45 (s, 3 H), 2.64-2.72 (m, 2 H), 3.07 (m, 1 H), 3.97-4.10 (m, 2 H), 4.35 (d, J = 16.8 Hz, 1 H), 5.45 (m, 1 H), 5.59 (m, 1 H), 5.98 (s, 1 H), 7.36 (d, J = 8.0 Hz, 2 H), 7.74 (d, J = 8.3 Hz, 2 H) ppm. 13C NMR (CDCl3): δ = 18.4, 21.8, 47.9, 50.5, 52.2, 56.1, 124.9, 125.5, 127.7, 130.2, 130.6, 133.4, 144.4, 176.6, 207.5 ppm. IR: νCO = 1710 cm-1. HRMS: m/z calcd for C17H19O3NS: 317.1086; found: 317.1085.
5-Oxo-6-phenyl-4-propenyl-3,3a,4,5-tetrahydro-1
H
-pentalene-2,2-dicarboxylic Acid Diethyl Ester (2e).
1H NMR (CDCl3): δ = 1.07 (t, J = 7.1 Hz, 3 H), 1.15 (t, J = 7.1 Hz, 3 H), 1.60 (d, J = 5.8 Hz, 3 H), 1.70 (t, J = 12.4 Hz, 1 H), 2.69-2.78 (m, 2 H), 2.87 (m, 1 H), 3.16 (d, J = 19.5 Hz, 1 H), 3.50 (d, J = 19.4 Hz, 1 H), 4.01 (m, 2 H), 4.13 (dd, J = 7.0, 14.1 Hz, 2 H), 5.42 (m, 1 H), 5.54 (m, 1 H), 7.12-7.43 (m, 5 H) ppm. 13C NMR (CDCl3): δ = 14.1, 14.2, 18.3, 36.1, 38.4, 50.0, 58.8, 61.3, 61.5, 62.10, 62.13, 63.3, 126.8, 128.3, 128.48, 128.55, 129.6, 131.2, 134.3, 170.8, 171.7, 176.2, 206.8 ppm. IR: νCO = 1723 cm-1. HRMS: m/z calcd for C23H26O5: 382.1780; found: 382.1780.
6-Methyl-5-oxo-4-propenyl-3,3a,4,5-tetrahydro-1
H
-pentalene-2,2-dicarboxylic Acid Diethyl Ester (2f).
1H NMR (CDCl3): δ = 1.21 (m, 6 H), 1.65-1.67 (m, 6 H), 1.73 (m, 1 H), 2.64 (m, 1 H), 2.77 (m, 2 H), 3.13 (dd, J = 18.9, 28.1 Hz, 2 H), 4.16 (m, 4 H), 5.41 (m, 1 H), 5.56 (m, 1 H) ppm. 13C NMR (CDCl3): δ = 9.0, 14.2, 18.4, 34.1, 38.8, 49.8, 57.5, 61.1, 62.1, 62.3, 127.1, 129.4, 131.9, 171.2, 175.5, 209.2 ppm. IR: νCO = 1722 cm-1. HRMS: m/z calcd for C18H24O5: 320.1624; found: 320.1621.
5-Oxo-4-propenyl-3,3a,4,5-tetrahydro-1
H
-pentalene-2,2-dicarboxylic Acid Diethyl Ester (
2g).
1H NMR (CDCl3): δ = 1.28 (m, 6 H), 1.74 (d, J = 6.2 Hz, 3 H), 1.84 (t, J = 12.5 Hz, 1 H), 2.78 (m, 1 H), 2.84 (dd, J = 7.8, 12.8 Hz, 1 H), 3.00 (m, 1 H), 3.30 (dd, J = 19.1, 36.9 Hz, 2 H), 4.24 (m, 4 H), 5.48 (m, 1 H), 5.63 (m, 1 H), 5.93 (m, 1 H) ppm. 13C NMR (CDCl3): δ = 14.2, 18.3, 35.3, 38.5, 51.8, 58.4, 61.0, 62.2, 62.3, 124.4, 126.6, 129.8, 170.1, 171.6, 183.3, 209.4 ppm. IR: νCO = 1723 cm-1. HRMS: m/z calcd for C17H22O5: 306.1467; found: 306.1466.
7-Phenyl-2-(toluene-4-sulfonyl)-2,3,3a,6-tetrahydro-1
H
-isoindole (3h).
1H NMR (CDCl3): δ = 2.35 (s, 3 H), 2.63 (dd, J = 11.2, 8.8 Hz, 1 H), 2.83-2.88 (m, 1 H), 2.96-2.99 (m, 1 H), 3.05-3.22 (m, 1 H), 3.63 (d, J = 14.0 Hz, 1 H), 3.80 (dd, J = 8.7, 7.7 Hz, 1 H), 4.07-4.14 (m, 1 H), 5.67 (d, J = 10.3 Hz, 1 H), 5.80-5.86 (m, 1 H), 7.05 (d, J = 8.3 Hz, 2 H), 7.19-7.27 (m, 1 H), 7.58 (d, J = 8.3 Hz, 2 H) ppm. HRMS: m/z calculated for C21H21O2SN: 351.1293; found: 351.1296. Anal. Calcd for C21H21O2SN: C, 71.77; H, 6.02; N, 3.99. Found: C, 71.80; H, 5.69; N, 3.45.
7-Butyl-2-(toluene-4-sulfonyl)-2,3,3a,6-tetrahydro-1
H
-isoindole (3i).
1H NMR (CDCl3): δ = 0.87 (t, J = 7.1 Hz, 3 H), 1.21-1.31 (m, 4 H), 1.81-2.01 (m, 2 H), 2.42 (s, 3 H), 2.45-2.53 (m, 1 H), 2.57 (dd, J = 11.5, 8.6 Hz, 2 H), 2.93-3.11 (m, 1 H), 3.79-3.84 (m, 2 H), 3.97 (d, J = 13.2 Hz, 1 H), 5.65 (d, J = 9.9 Hz, 2 H), 5.75-5.81 (m, 1 H), 7.31 (d, J = 8.0 Hz, 2 H), 7.72 (d, J = 8.2 Hz, 2 H) ppm. 13C NMR (CDCl3): δ = 14.3, 19.0, 23.2, 29.1, 30.5, 33.5, 49.1, 52.9, 55.5, 127.2, 127.8, 128.7, 128.9, 129.9, 131.1 ppm. HRMS: m/z calcd for C19H25O2SN: 331.1606; found: 331.1601.
2-(Toluene-4-sulfonyl)-2,3,3a,6-tetrahydro-1
H
-isoindole (3j).
1H NMR (CDCl3): δ = 2.42 (s, 3 H), 2.62-2.70 (m, 3 H), 2.98 (t, J = 8.3 Hz, 1 H), 3.73 (d, J = 13.1 Hz, 1 H), 3.83 (t, J = 8.3 Hz, 1 H), 3.98-4.04 (m, 1 H), 5.50-5.58 (m, 1 H), 5.62-5.69 (m, 1 H), 5.72-5.83 (m, 1 H), 7.31 (d, J = 8.4 Hz, 2 H), 7.71 (d, J = 8.3 Hz, 2 H) ppm.
(
E
)-4-Ethylidene-6-phenyl-2-(toluene-4-sulfonyl)-2,3,3a,4-tetrahydro-1
H
-cyclopenta[
c
]pyrrol-5-one (5h).
1H NMR (CDCl3): δ = 1.92 (d, J = 7.2 Hz, 3 H), 2.40 (s, 3 H), 2.60 (dd, J = 10.9, 9.0 Hz, 1 H), 3.74 (t, J = 8.6 Hz, 1 H), 4.03 (dd, J = 16.3, 1.5 Hz, 1 H), 4.22 (t, J = 8.6 Hz, 1 H), 4.66 (dd, J = 16.3, 1.7 Hz, 1 H), 6.79 (qd, J = 7.2, 1.9 Hz, 1 H), 7.29 (d, J = 8.2 Hz, 2 H), 7.37-7.45 (m, 3 H), 7.49-7.53 (m, 2 H), 7.70 (d, J = 8.3 Hz, 2 H) ppm. 13C NMR (CDCl3): δ = 15.8, 21.7, 44.8, 48.1, 50.1, 127.5, 128.4, 128.8, 129.1, 130.2, 130.6, 132.9, 133.9, 137.2, 137.7, 144.2, 165.8, 195.3 ppm. IR: νCO = 1699 cm-1. HRMS: m/z calcd for C22H21O3SN: 379.1242; found: 379.1242. Anal. Calcd for C22H21O3SN: C, 69.63; H, 5.58; N, 5.58. Found: C, 69.73; H, 6.02; N, 3.26.
(
E
)-6-Butyl-4-ethylidene-2-(toluene-4-sulfonyl)-2,3,3a,4-tetrahydro-1
H
-cyclopenta[
c
]pyrrol-5-one (5i).
1H NMR (CDCl3): δ = 0.77 (t, J = 7.2 Hz, 3 H), 1.04-1.18 (m, 2 H), 1.21-1.30 (m, 2 H), 1.78 (d, J = 7.1 Hz, 3 H), 1.96-2.05 (m, 1 H), 2.11-2.21 (m, 1 H), 2.36 (s, 3 H), 2.46 (dd, J = 10.9, 9.0 Hz, 1 H), 3.48 (t, J = 9.0 Hz, 1 H), 3.91 (d, J = 15.5 Hz, 1 H), 4.05 (t, J = 8.5 Hz, 1 H), 4.19 (d, J = 15.6 Hz, 1 H), 6.56 (qd, J = 7.13, 1.6 Hz, 1 H), 7.27 (d, J = 8.1 Hz, 2 H), 7.66 (d, J = 8.2 Hz, 2 H) ppm. 13C NMR (CDCl3): δ = 13.9, 15.7, 21.7, 22.6, 24.2, 30.0, 44.5, 46.5, 50.8, 127.6, 130.1, 131.7, 133.6, 136.7, 140.2, 144.2, 164.3, 195.3 ppm. IR: νCO = 1698 cm-1. HRMS: m/z calcd for C20H25O3SN: 359.1555; found: 359.1550.
(
Z
)-4-Ethylidene-6-phenyl-2-(toluene-4-sulfonyl)-2,3,3a,4-tetrahydro-1
H
-cyclopenta[
c
]pyrrol-5-one (6h).
1H NMR (CDCl3): δ = 2.27 (dd, J = 7.4, 1.1 Hz, 3 H), 2.40 (s, 3 H), 2.57 (dd, J = 10.8, 9.0 Hz, 1 H), 3.67 (t, J = 9.9 Hz, 1 H), 4.02 (dd, J = 16.5, 1.5 Hz, 1 H), 4.05 (t, J = 8.6 Hz, 1 H), 4.65 (dd, J = 16.4, 1.7 Hz, 1 H), 6.18 (qd, J = 7.4, 1.4 Hz, 1 H), 7.30 (d, J = 8.2 Hz, 2 H), 7.37-7.44 (m, 3 H), 7.49-7.52 (m, 2 H), 7.70 (d, J = 8.3 Hz, 2 H) ppm. 13C NMR (CDCl3): δ = 14.3, 23.9, 46.8, 48.5, 50.7, 127.6, 128.5, 130.2, 130.7, 131.1, 132.7, 133.9, 135.9, 136.9, 138.9, 144.2, 167.9, 194.8 ppm. IR: νCO = 1694 cm-1. HRMS: m/z calcd for C22H21O3SN: 379.1242; found: 379.1239.
(
Z
)-6-Butyl-4-ethylidene-2-(toluene-4-sulfonyl)-2,3,3a,4-tetrahydro-1
H
-cyclopenta[
c
]pyrrol-5-one (6i).
1H NMR (CDCl3): δ = 0.76-0.81 (m, 3 H), 1.10-1.30 (m, 4 H), 1.44-1.58 (m, 2 H), 2.12 (d, J = 7.4 Hz, 3 H), 2.36 (s, 3 H), 2.44 (dd, J = 10.8, 8.9 Hz, 1 H), 3.40 (t, J = 9.1 Hz, 1 H), 3.86-3.93 (m, 2 H), 4.13-4.17 (m, 1 H), 5.60 (qd, J = 7.4, 1.2 Hz, 1 H), 7.27 (d, J = 8.0 Hz, 2 H), 7.65 (d, J = 8.0 Hz, 2 H) ppm. 13C NMR (CDCl3): δ = 11.1, 13.9, 21.7, 22.7, 24.1, 30.0, 38.9, 46.9, 51.4, 127.6, 130.1, 131.1, 135.2, 135.9, 141.4, 144.2, 163.9 ppm. IR: νCO = 1692 cm-1. HRMS: m/z calcd for C20H25O3SN: 359.1555; found: 359.1553.